Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.
Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L.
Xia S, et al. Among authors: kilari d.
Oncotarget. 2015 Jun 30;6(18):16411-21. doi: 10.18632/oncotarget.3845.
Oncotarget. 2015.
PMID: 25915538
Free PMC article.